N-Cadherin Antikörper (AA 750-850)
Kurzübersicht für N-Cadherin Antikörper (AA 750-850) (ABIN3017243)
Target
Alle N-Cadherin (CDH2) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    
- 
                                            
Bindungsspezifität
 - AA 750-850
 - 
                                            
Sequenz
 - DKERQAKQLL IDPEDDVRDN ILKYDEEGGG EEDQDYDLSQ LQQPDTVEPD AIKPVGIRRM DERPIHAEPQ YPVRSAAPHP GDIGDFINEG LKAADNDPTA P
 - 
                                            
Kreuzreaktivität
 - Human, Maus, Ratte
 - 
                                            
Produktmerkmale
 - Polyclonal Antibodies
 - 
                                            
Aufreinigung
 - Affinity purification
 - 
                                            
Immunogen
 - A synthetic peptide corresponding to a sequence within amino acids 750-850 of human N-Cadherin (NP_001783.2).
 - 
                                            
Isotyp
 - IgG
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Applikationshinweise
 - WB,1:500 - 1:1000,IP,1:50 - 1:100
 - 
                                            
Beschränkungen
 - Nur für Forschungszwecke einsetzbar
 
 - 
                                            
 - 
    
- 
                                            
Buffer
 - PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
 - 
                                            
Konservierungsmittel
 - Sodium azide
 - 
                                            
Vorsichtsmaßnahmen
 - This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 - 
                                            
Lagerung
 - -20 °C
 - 
                                            
Informationen zur Lagerung
 - Store at -20°C. Avoid freeze / thaw cycles.
 
 - 
                                            
 - 
    
- 
                                            : "ARRDC3 suppresses colorectal cancer progression through destabilizing the oncoprotein YAP."    in: FEBS letters, Vol. 592, Issue 4, pp. 599-609, (2019)         (PubMed).        
: "CO suppresses prostate cancer cell growth by directly targeting LKB1/AMPK/mTOR pathway in vitro and in vivo." in: Urologic oncology, Vol. 36, Issue 6, pp. 312.e1-312.e8, (2018) (PubMed).
 
 - 
                                            : "ARRDC3 suppresses colorectal cancer progression through destabilizing the oncoprotein YAP."    in: FEBS letters, Vol. 592, Issue 4, pp. 599-609, (2019)         (PubMed).        
 - 
    
- N-Cadherin (CDH2) (Cadherin 2 (CDH2))
 - 
                                            
Andere Bezeichnung
 - CDH2
 - 
                                            
Hintergrund
 - This gene encodes a classical cadherin and member of the cadherin superfamily. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein is proteolytically processed to generate a calcium-dependent cell adhesion molecule and glycoprotein. This protein plays a role in the establishment of left-right asymmetry, development of the nervous system and the formation of cartilage and bone.,CD325,CDHN,CDw325,NCAD,N Cadherin,CDH2,Cancer,Invasion and Metastasis,Signal Transduction,Cell Biology & Developmental Biology,Cell Cycle,Centrosome,Cell Adhesion,Cadherins,Tight Junctions,Cytoskeleton,Wnt/β-Catenin Signaling Pathway,Immunology & Inflammation,CD markers,Stem Cells,Hematopoietic Progenitors,CDH2
 - 
                                            
Molekulargewicht
 - 97 kDa/99 kDa
 - 
                                            
Gen-ID
 - 1000
 - 
                                            
UniProt
 - P19022
 - 
                                            
Pathways
 - Regulation of Muscle Cell Differentiation, Cell-Cell Junction Organization, Synaptic Membrane
 
Target
 -